Screening Technology definition

Screening Technology means, collectively, Screening Know-How and Screening Patents.
Screening Technology means Instruments, Hardware Units, Hardware Unit Software, Data Handling Software, LabChip HTS Assays, LabChip UHTS Assays, and LabChips for HTS or UHTS that Caliper offers for commercial sale to TAP participants.
Screening Technology shall have the meaning given in the first recital.

Examples of Screening Technology in a sentence

  • Amgen covenants that it will not utilize Screening Technology for the purpose of screening for calcilytic compounds.

  • Except as otherwise provided herein, NPS shall retain all other rights in connection with the Screening Technology.

  • Assuming that in future applications the Vertebrate Automated Screening Technology system can also be connected to the large particle flow cytometer technology without the need of prior dispensing larvae into multi well plates, will lead to a more advanced sorting.

  • This can be done using the Vertebrate Automated Screening Technology [15, 16].

  • Screening Technology A mechanical fine screen system will be added to enhance the preliminary treatment processes and improve overall WRRF performance.


More Definitions of Screening Technology

Screening Technology means the Instruments, LabChips, reagents and software, and associated Caliper Patents and Caliper Know-how, utilized by Caliper for high throughput screening activities under this Agreement, excluding Caliper Compounds.
Screening Technology means pulse oximetry testing in the right hand and either foot.
Screening Technology means any Intellectual Property Rights now or hereafter owned by SIDDCO, or licensed to SIDDCO by a third party related to research or development work for testing compounds for activity on a Drug Discovery Target(s).
Screening Technology means, collectively, Screening Know-How and Screening Patents. Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. APPENDIX B [* * *] Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. APPENDIX C [* * *] Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. APPENDIX D [* * *] Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. APPENDIX E [* * *] Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. APPENDIX F [* * *] Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. APPENDIX G [* * *] Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. APPENDIX H [* * *] Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. APPENDIX I [* * *] Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. APPENDIX J [* * *] Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission. APPENDIX K [* * *]
Screening Technology means pulse oximetry testing in the right hand and either foot. Screening technology shall also include alternate medically accepted tests that measure the percentage of blood oxygen saturation, follow medical guideline consensus and recommendations issued by the American Academy of Pediatrics, and are approved by the State Board of Health.

Related to Screening Technology

  • Licensed Technology means the Licensed Know-How and Licensed Patents.

  • Biological Materials means certain tangible biological materials that are necessary for the effective exercise of the Patent Rights, which materials are described on Exhibit A, as well as tangible materials that are routinely produced through use of the original materials, including, for example, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from isolated DNA or RNA, recombinant proteins produced through use of isolated DNA or RNA, and substances routinely purified from a source material included in the original materials (such as recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). These Biological Materials shall be listed on Exhibit A, which will be periodically amended to include any additional Biological Materials that Medical School may furnish to Company.

  • Customer Technology means Customer's proprietary technology, including Customer's Internet operations design, content, software tools, hardware designs, algorithms, software (in source and object forms), user interface designs, architecture, class libraries, objects and documentation (both printed and electronic), know-how, trade secrets and any related intellectual property rights throughout the world (whether owned by Customer or licensed to Customer from a third party) and also including any derivatives, improvements, enhancements or extensions of Customer Technology conceived, reduced to practice, or developed during the term of this Agreement by Customer.

  • Company Technology means all Technology owned or purported to be owned by the Company.

  • Biological Material means any material containing genetic information and capable of reproducing itself or being reproduced in a biological system;

  • Assistive technology means the devices, aids, controls, supplies, or appliances described in OAR 411-300-0150 that are purchased to provide support for a child and replace the need for direct interventions to enable self-direction of care and maximize independence of the child.

  • Technology means any and all technical information, specifications, drawings, records, documentation, works of authorship or other creative works, ideas, algorithms, models, databases, ciphers/keys, systems architecture, network protocols, research, development, and manufacturing information, software (including object code and source code), application programming interfaces (APIs), innovations, mask works, logic designs, circuit designs, technical data, processes and methods.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Licensed Know-How means all Know-How that (a) is Controlled by Pfizer or any of its Affiliates as of the effective date of the Pfizer-MPP Agreement, (b) directly relates to the use of the Compound, Product or Licensed Product in the Field, and (c) is not in the public domain or otherwise generally known. For the avoidance of doubt, (i) Licensed Know-How shall not include any Know-How to the extent solely and directly related to any other Pfizer compound or to the extent related to the use of the Compound, Product or Licensed Product outside the Field and (ii) Licensed Know-How includes only that Know-How, designated by Pfizer in its sole discretion, necessary for the manufacture, registration and commercialization of the Compound and/or Licensed Product for use in the Field. For the avoidance of doubt, Licensed Know-How excludes any Know-How related to ritonavir that has been (either as of the Effective Date or at any time during the term of this Agreement) in-licensed by Pfizer from any Third Party.